Home The Word Brain My Amedeo FAQ Privacy About   


C49 + CC Journal Club

For more information, please refer to our special emails from April 13 and May 19.


  Hyperlipoproteinemias

  Free Subscription


Articles published in Arterioscler Thromb Vasc Biol

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    June 2025
  1. AGUILAR V, Le Master E, Paul A, Ahn SJ, et al
    Endothelial Stiffening Induced by CD36-Mediated Lipid Uptake Leads to Endothelial Barrier Disruption and Contributes to Atherosclerotic Lesions.
    Arterioscler Thromb Vasc Biol. 2025;45:e201-e216.
    PubMed     Abstract available


    January 2025
  2. AMIOKA N, Franklin MK, Kukida M, Zhu L, et al
    Renal Proximal Tubule Cell-Specific Megalin Deletion Does Not Affect Atherosclerosis But Induces Tubulointerstitial Nephritis in Mice Fed a Western Diet.
    Arterioscler Thromb Vasc Biol. 2025;45:74-89.
    PubMed     Abstract available


    December 2024
  3. GIANOS E, Duell PB, Toth PP, Moriarty PM, et al
    Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association.
    Arterioscler Thromb Vasc Biol. 2024;44:e304-e321.
    PubMed     Abstract available


    November 2024
  4. TURKSON V, Haller A, Jaeschke A, Hui DY, et al
    ApoE Receptor-2 R952Q Variant in Macrophages Elevates Soluble LRP1 to Potentiate Hyperlipidemia and Accelerate Atherosclerosis in Mice.
    Arterioscler Thromb Vasc Biol. 2024 Nov 7. doi: 10.1161/ATVBAHA.124.321748.
    PubMed     Abstract available


  5. BASHIR B, Downie P, Forrester N, Wierzbicki AS, et al
    Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.
    Arterioscler Thromb Vasc Biol. 2024;44:2334-2346.
    PubMed     Abstract available


    September 2024
  6. CHAIX A, Lin T, Ramms B, Cutler RG, et al
    Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice.
    Arterioscler Thromb Vasc Biol. 2024;44:2069-2087.
    PubMed     Abstract available


    June 2024
  7. VERGES B, Vantyghem MC, Reznik Y, Duvillard L, et al
    Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy.
    Arterioscler Thromb Vasc Biol. 2024 Jun 20. doi: 10.1161/ATVBAHA.124.320774.
    PubMed     Abstract available


  8. TANG SY, Lordan R, Meng H, Auerbach BJ, et al
    Differential Impact In Vivo of Pf4-DeltaCre-Mediated and Gp1ba-DeltaCre-Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice.
    Arterioscler Thromb Vasc Biol. 2024;44:1393-1406.
    PubMed     Abstract available


    May 2024
  9. TRINDER M, Cermakova L, Ruel I, Baass A, et al
    Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 23. doi: 10.1161/ATVBAHA.123.320287.
    PubMed     Abstract available


  10. BELIARD S, Saheb S, Litzler-Renault S, Vimont A, et al
    Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 2. doi: 10.1161/ATVBAHA.123.320609.
    PubMed     Abstract available


    March 2024
  11. RAAL FJ, Hegele RA, Ruzza A, Lopez JAG, et al
    Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.
    Arterioscler Thromb Vasc Biol. 2024 Mar 28. doi: 10.1161/ATVBAHA.123.320268.
    PubMed     Abstract available


    November 2023
  12. PAQUETTE M, Cariou B, Bernard S, Hegele RA, et al
    Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2023 Nov 30. doi: 10.1161/ATVBAHA.123.319957.
    PubMed     Abstract available


  13. DUBNER AM, Lu S, Jolly AJ, Noble T, et al
    Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research-Brief Report.
    Arterioscler Thromb Vasc Biol. 2023;43:2223-2230.
    PubMed     Abstract available


    September 2023
  14. GRATTON J, Humphries SE, Futema M
    Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report.
    Arterioscler Thromb Vasc Biol. 2023;43:1737-1742.
    PubMed     Abstract available


    August 2023
  15. BERRY ASF, Jones LK, Sijbrands EJ, Gidding SS, et al
    Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2023 Aug 17. doi: 10.1161/ATVBAHA.123.319341.
    PubMed     Abstract available


    July 2023
  16. MENG FH, Liu S, Xiao J, Zhou YX, et al
    New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol.
    Arterioscler Thromb Vasc Biol. 2023;43:1219-1233.
    PubMed     Abstract available


    June 2023
  17. BEA AM, Larrea-Sebal A, Marco-Benedi V, Uribe KB, et al
    Contribution of APOE Genetic Variants to Dyslipidemia.
    Arterioscler Thromb Vasc Biol. 2023;43:1066-1077.
    PubMed     Abstract available


    May 2023
  18. LEWIS EA, Muniz-Anquela R, Redondo-Angulo I, Gonzalez-Cintado L, et al
    Capacity for LDL (Low-Density Lipoprotein) Retention Predicts the Course of Atherogenesis in the Murine Aortic Arch.
    Arterioscler Thromb Vasc Biol. 2023;43:637-649.
    PubMed     Abstract available


    April 2023
  19. MARMONTEL O, Abou-Khalil Y, Bluteau O, Cariou B, et al
    Additive Effect of APOE Rare Variants on the Phenotype of Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2023 Apr 27. doi: 10.1161/ATVBAHA.123.319146.
    PubMed     Abstract available


  20. ARNDT L, Hernandez-Resendiz I, Moos D, Dokas J, et al
    Trib1 Deficiency Promotes Hyperlipidemia, Inflammation, and Atherosclerosis in LDL (Low-Density Lipoprotein) Receptor Knockout Mice.
    Arterioscler Thromb Vasc Biol. 2023 Apr 20. doi: 10.1161/ATVBAHA.122.318137.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.